Jeffrey Burris - Indivior PLC Chief Officer

IZQVFDelisted Stock  USD 23.94  0.35  1.44%   

Insider

Jeffrey Burris is Chief Officer of Indivior PLC
Age 51
Phone804 379 1090
Webhttps://www.indivior.com

Indivior PLC Management Efficiency

The company has return on total asset (ROA) of 0.0697 % which means that it generated a profit of $0.0697 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.8557 %, meaning that it generated $0.8557 on every $100 dollars invested by stockholders. Indivior PLC's management efficiency ratios could be used to measure how well Indivior PLC manages its routine affairs as well as how well it operates its assets and liabilities.
Indivior PLC has accumulated 239 M in total debt with debt to equity ratio (D/E) of 1.22, which is about average as compared to similar companies. Indivior PLC has a current ratio of 1.67, which is within standard range for the sector. Debt can assist Indivior PLC until it has trouble settling it off, either with new capital or with free cash flow. So, Indivior PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Indivior PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Indivior to invest in growth at high rates of return. When we think about Indivior PLC's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Adalmario CoutoHypera SA
N/A
A MBACumberland Pharmaceuticals
67
Joao AguilarHypera SA
N/A
Thomas HarveyAlkermes Plc
N/A
Keith KatkinEmergent Biosolutions
48
Lynn KiefferEmergent Biosolutions
N/A
Floyd MDAlkermes Plc
88
Hlio SegourasHypera SA
N/A
Cindy PattonCumberland Pharmaceuticals
71
Adam MostafaCumberland Pharmaceuticals
45
Juliana SalemHypera SA
N/A
Karen SmithEmergent Biosolutions
52
Jennifer FoxEmergent Biosolutions
51
Luiz ClavisHypera SA
N/A
Marvin WhiteEmergent Biosolutions
58
Robert SrEmergent Biosolutions
67
Mauricio ChristovamHypera SA
N/A
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia. Indiviorplc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 900 people. Indivior PLC [IZQVF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Indivior PLC Leadership Team

Elected by the shareholders, the Indivior PLC's board of directors comprises two types of representatives: Indivior PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Indivior. The board's role is to monitor Indivior PLC's management team and ensure that shareholders' interests are well served. Indivior PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Indivior PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jon Fogle, Chief Human Resource Officer
Nina DeLorenzo, Chief Officer
Jeffrey Burris, Chief Officer
Jason Thompson, VP Relations
Christian Heidbreder, Chief Scientific Officer and Head of RandD
Richard Simkin, Chief Commercial and Strategy Officer
Ryan Preblick, CFO Director
Mark Crossley, CFO, Director
Hillel West, Chief Officer
Cynthia Cetani, Chief Officer

Indivior Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Indivior PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Indivior Pink Sheet

If you are still planning to invest in Indivior PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Indivior PLC's history and understand the potential risks before investing.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.